The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML. The $1,687.64 order has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is a prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was not set aside for any small business category.
Generated 5/8/24, 9:40 AM